High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: Comparison with chronic stable angina and normal controls

Heart

Volumn 96, Issue 23, 2010, Pages 1926-1931

  Chimenti, Cristina ^a,b   Sale, Patrizio ^a,c   Verardo, Romina ^b   Cicalini, Stefania ^b   Petrosillo, Nicola ^b   Russo, Matteo A ^a,c   Fedele, Francesco ^a   Frustaci, Andrea ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; NITRATE; XANTHINE DERIVATIVE;

ADENOVIRUS; ADULT; ARTICLE; CARDIOVASCULAR INFECTION; CHRONIC STABLE ANGINA; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAMURAL CORONARY INFECTION; LASER MICRODISSECTION; MALE; MITRAL VALVE STENOSIS; MIXED INFECTION; MYOCARDITIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; SYNDROME X; TREATMENT RESPONSE; VASCULITIS; VIRUS GENOME; VIRUS INFECTION;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY DISEASE; DRUG RESISTANCE, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MICROVASCULAR ANGINA; MIDDLE AGED; RECURRENCE; VIRUS DISEASES;

EID: 78649904814     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.196626     Document Type: Article

References (30)

1. Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary angiograms. Am J Cardiol 1973;32:375-6.
2. Lanza GA, Giordano AG, Pristipino C, et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I] metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997;96:821-6.
3. Lanza GA, Buffon A, Sestito A, et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 2008;51:466-72.
4. Chauhan A, Mullins PA, Taylor G, et al. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997;18:60-8. (Pubitemid 27105772)
5. Mohri M, Shimokawa H, Hirakawa Y, et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003;41:15-19. (Pubitemid 36044397)
6. Botker HE, Moller N, Schmitz O, et al. Myocardial insulin resistance in patients with syndrome X. J Clin Invest 1997;100:1919-27. (Pubitemid 27459344)
7. Rosano GM, Ponikowski P, Adamopoulos S, et al. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994;73:1174-9.
8. Gaspardone A, Ferri C, Crea F, et al. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol 1998;32:2031-4.
9. Lanza GA, Lüscher TF, Pasceri V, et al. Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol 1999;84: 1187-91.
10. Rosano GM, Collins P, Kaski JC, et al. Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995;16:610-14.
11. Cosin-Sales J, Pizzi C, Brown S, et al. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 2003;41:1468-74.
12. Assadi M, Saghari M, Ebrahimi A, et al. The relation between Helicobacter pylori infection and cardiac syndrome X: a preliminary study. Int J Cardiol 2009;134:e124-5.
13. Master AM. The spectrum of anginal and noncardiac chest pain. JAMA 1964;187:894-9.
14. Buffon A, Rigattieri S, Santini SA, et al. Myocardial ischemia - reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol Heart Circ Physiol 2000;279:H2627-33.
15. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995-2002.
16. Chimenti C, Russo A, Pieroni M, et al. Intramyocyte detection of Epstein - Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy. Circulation 2004;110:3534-9. (Pubitemid 39612567)
17. Potenza L, Luppi M, Barozzi P, et al. HHV-6A in syncytial giant-cell hepatitis. N Engl J Med 2008;359:593-602.
18. Mosseri M, Yarom R, Gotsman MS, et al. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-72.
19. Lanza GA, Sestito A, Cammarota G, et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 2004;94:40-4.
20. Cannon RO 3rd, Curiel RV, Prasad A, et al. Comparison of coronary endothelial dynamics with electrocardiographic and left ventricular contractile responses to stress in the absence of coronary artery disease. Am J Cardiol. 1998;82:710-14.
21. Nihoyannopoulos P, Kaski JC, Crake T, et al. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991;18:1463-70.
22. Camici PG, Marraccini P, Lorenzoni R, et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol 1991;17:1461-70.
23. Pizzi C, Manfrini O, Fontana F, et al. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 2004;109:53-8.
24. Vallbracht KB, Schwimmbeck PL, Kühl U, et al. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 2005;111:1784-91.
25. Angelini A, Calzolari V, Calabrese F, et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 2000;84:245-50.
26. Caruso A, Rotola A, Comar M, et al. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 2002;67:528-33.
27. Mosialos G, Birkenbach M, Yalamanchili R, et al. The EpsteineBarr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995;80:389-99.
28. Kühl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005;111:887-93.
29. Noutsias M, Fechner H, de Jonge H, et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001;104:275-80.
30. Zorc-Pleskovic R, Vraspir-Porenta O, Zorc M, et al. Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein. Folia Biol (Praha) 2008;54:30-2.